Axa’s Prestige Consumer Healthcare PBH Stock Holding History

Axa’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,700	Closed	-$320K	–	1256
2021 Q3	$320K	Buy	+5,700	New	+$313K	﹤0.01%	1137

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCAM

Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Axa's PBH Position: Q4 2021 in Review

Axa sold out of Prestige Consumer Healthcare (PBH) in Q4 2021, closing a stake of 5,700 shares — an estimated $320K sold.

Axa first reported a position in PBH in Q3 2021 and held it in 1 quarter. The position peaked at $320K in Q3 2021. 272 funds tracked by Wall St. Rank hold PBH as of Q4 2021.

Axa reported no remaining Prestige Consumer Healthcare position as of Q4 2021 after selling out during the quarter.
Axa sold 5,700 Prestige Consumer Healthcare shares in Q4 2021, an estimated $320K.
Axa first reported a position in Prestige Consumer Healthcare in Q3 2021 and held it in 1 quarter.
Axa's Prestige Consumer Healthcare position peaked at $320K in Q3 2021.
272 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2021.

Based on Axa's 13F filing for Q4 2021, filed 14 Feb 2022.